University of Alabama at Birmingham
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Alabama at Birmingham sits in the top decile of US sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count).
University of Alabama at Birmingham: 1,160 sponsored US clinical trials, 216 recruiting.
University of Alabama at Birmingham sponsors 1,160 registered US clinical trials on ClinicalTrials.gov, 216 of them currently recruiting, and 723 completed. 97 of these trials are in Phase 3-4 (later-stage) and 259 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
University of Alabama at Birmingham ranks in the top decile of sponsors by registered trial count (#26 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
723 of 812 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,160 total, page 5 of 24
Early Withdrawal Exposure and Negative Affect Withdrawal (NAW) Regulation Training for Smoking Cessation
NCT03912194
The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
NCT03538665
Glaucoma, Visual Field Loss, and Their Association With Life Space in Older Adults
NCT04396002
Ivacaftor for Acquired CFTR Dysfunction in Chronic Rhinosinusitis
NCT03439865
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
NCT03759522
UAB Alzheimer's Disease Center Core Cohort - Imaging Substudy
NCT03503331
The University of Alabama At Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) Substudy
NCT03457493
Red Light Treatment in Peripheral Artery Disease
NCT03203239
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
NCT03403686
Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy
NCT03403699
Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness
NCT03321045
Cognitive Training Intervention and Attitudes Towards Genetics
NCT03094026
Nasal Potential Difference (NPD) Protocol in Chronic Rhinosinusitis
NCT02038166
Peripheral Blood Flow Responses to Electromagnetic Energy
NCT02370199
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
NCT02043691
Regulation of Inflammatory Genes in Psoriasis
NCT03125655
Motivational Interviewing to Improve Oral Hygiene in Adolescent Orthodontic Patients
NCT07164989
Adapted High-Intensity Virtual Reality Exergaming
NCT07155213
Addressing Pain Through Navigator-Led Palliative Care Optimized for Heart Failure (ADAPT-HF)
NCT06270875
Design and Delivery Preferences for Exercise Intervention in People With Spinal Cord Injury
NCT06578780
An Optimization Pilot to Optimize An Early Palliative Care Intervention for Advanced Heart Failure
NCT05879887
Monitoring Blood Pressure at Home
NCT06247111
Cancer PRevention Through Enhanced EnvironMenT
NCT06864260
A Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)
NCT06240351
Probiotics and Insulin Resistance in Obese Asthmatics
NCT05949255
Vaginal Orthosis Use After Vaginal Reconstructive Surgery
NCT05812859
Addition of Loncastuximab Tesirine to Acalbrutinib , Chronic Lymphocytic Leukemia
NCT05971251
OPERATION WIPE OUT: Multi-Channel Communication Campaign to Promote HPV Vaccination in Chambers County, Alabama
NCT06247124
Bodewell Products for the Treatment of Atopic Dermatitis
NCT05566262
Hearty Meals for Mom- Pilot Study of Meal Delivery for Cardiometabolic Health During Pregnancy
NCT05512247
Study on Use of Omega-3 Fatty Acids to Improve Outcomes in Individuals With Sickle Cell Disease
NCT05758766
Healthier At-home Meals for Expectant Mothers
NCT05605340
Platelet Rich Plasma as an Adjunct Therapy at the Time of Transvaginal Native Tissue Prolapse Surgery
NCT05731284
Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI
NCT05377242
Promoting Increases in Living Donation Via Tele-navigation (PILOT)
NCT05468463
Stepping Into Lifestyle Changes
NCT05625321
Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm
NCT05615311
COMbination Regimens in MM Post AHCT to elimiNate MRD Utilizing IbERdomide
NCT05434689
Food Delivery, Remote Monitoring, and Coaching-Enhanced Education for Optimized Diabetes Management (FREEDOM)
NCT05288452
Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants
NCT05525585
Improving Primary Care Access to Urinary Incontinence Treatment for Women Veterans
NCT05438849
Factors in Learning And Plasticity: Healthy Vision
NCT05439759
Equity in Prevention and Progression of Hypertension by Addressing Barriers to Nutrition and Physical activitY
NCT05367544
Transferring Speed of Processing Gains to Everyday Cognitive Tasks After Stroke
NCT05162781
Endovascular vs Surgical Arteriovenous Fistula Outcomes
NCT04404985
STROKE STAT (Stroke Severity-based Triage to Accelerate Treatment)
NCT04978480
Trem-1 and Ultraviolet Radiation-induced Immune Suppression
NCT05020496
Effects of Modulators of Gluconeogenesis, Glycogenolysis and Glucokinase Activity
NCT05098470
Glycemic Control After Antenatal Corticosteroids in Women With Pregestational and Gestational Diabetes
NCT04542148
Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial
NCT04803604
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 129 |
| Phase 2 | 130 |
| Phase 3 | 25 |
| Phase 4 | 72 |
Therapeutic Areas
What is open in the University of Alabama at Birmingham pipeline
216 recruiting of 1,160 indexed (19% open); 723 completed (62%).
Phase mix: 97 late (III/IV) vs 259 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Alabama at Birmingham: open-pipeline peers nationwide
Peers matched on 1,160 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Alabama at Birmingham sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,160 trials (± recruiting share)
- NYU Langone Health · 1,164 trials · 17% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Minnesota · 19% recruiting · 966 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Alabama at Birmingham page
1,160 registered trials is a research-attention snapshot, not an endorsement of University of Alabama at Birmingham or any single study.
- 216 of University of Alabama at Birmingham's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Alabama at Birmingham studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Alabama at Birmingham pipeline card: 1,160 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.